ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,356,000 | -9.9% | 20,700 | +9.5% | 0.01% | -10.0% |
| Q4 2020 | $2,616,000 | +56.8% | 18,900 | -6.9% | 0.01% | +42.9% |
| Q3 2020 | $1,668,000 | +148.2% | 20,300 | +136.0% | 0.01% | +133.3% |
| Q2 2020 | $672,000 | +244.6% | 8,600 | +95.5% | 0.00% | +200.0% |
| Q1 2020 | $195,000 | +170.8% | 4,400 | +158.8% | 0.00% | – |
| Q4 2019 | $72,000 | -66.0% | 1,700 | -66.0% | 0.00% | – |
| Q3 2019 | $212,000 | -41.3% | 5,000 | -12.3% | 0.00% | -100.0% |
| Q2 2019 | $361,000 | -8.6% | 5,700 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $395,000 | +441.1% | 5,700 | +235.3% | 0.00% | – |
| Q4 2018 | $73,000 | -82.6% | 1,700 | -69.1% | 0.00% | -100.0% |
| Q3 2018 | $419,000 | -0.7% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $422,000 | +591.8% | 5,500 | +358.3% | 0.00% | – |
| Q1 2018 | $61,000 | +306.7% | 1,200 | +300.0% | 0.00% | – |
| Q3 2017 | $15,000 | -92.2% | 300 | -90.3% | 0.00% | -100.0% |
| Q2 2017 | $192,000 | -8.6% | 3,100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $210,000 | +7.1% | 3,100 | +10.7% | 0.00% | 0.0% |
| Q4 2016 | $196,000 | -27.1% | 2,800 | -26.3% | 0.00% | 0.0% |
| Q3 2016 | $269,000 | -12.7% | 3,800 | -39.7% | 0.00% | 0.0% |
| Q2 2016 | $308,000 | -66.7% | 6,300 | -56.8% | 0.00% | -75.0% |
| Q1 2016 | $924,000 | -45.4% | 14,600 | -3.3% | 0.00% | -50.0% |
| Q4 2015 | $1,693,000 | +16.4% | 15,100 | 0.0% | 0.01% | +14.3% |
| Q3 2015 | $1,454,000 | -0.7% | 15,100 | +5.6% | 0.01% | +16.7% |
| Q2 2015 | $1,464,000 | +77.5% | 14,300 | +7.5% | 0.01% | +50.0% |
| Q1 2015 | $825,000 | – | 13,300 | – | 0.00% | – |
| Q3 2014 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
| Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
| Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
| SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
| Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
| FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
| CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
| Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
| Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |